Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin gel as adjunct to xenograft for intrabony periodontal defects
NCT05360511Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Jul 2022
- Primary completion
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes, Hydrogel Systems
- Countries
- 1
01
Overview
Phase 1, randomised trial of erythropoietin chitosan gel in periodontitis, sponsored by Ain Shams University. Primary endpoint: Plaque Index at 6 months. Started Jul 2022; status: completed.
02
Drugs
erythropoietin chitosan gel
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT05360511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05360511.